Policy changes Backwork has recorded, newest first. The most recent change on record is from October 2, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
82,180 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Surgical Left Atrial Appendage Occlusion Devices for Stroke Prevention in Atrial Fibrillation | Retired |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Speech Therapy | Retired |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Rehabilitative Devices with Remote Monitoring | Retired |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Multimarker Serum Testing Related to Ovarian Cancer, Effective 9/1/2026 | Retired |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Multimarker Serum Testing Related to Ovarian Cancer | Retired |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Medicare Advantage Plans National and Local Coverage Determinations | Retired |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Low-Level Laser Therapy | Retired |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Gene Expression Profile Testing and Circulating Tumor DNA Testing for Predicting Recurrence in Colon Cancer | Retired |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Digital Health Technologies for Attention Deficit/Hyperactivity Disorder | Retired |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Corneal Topography/Computer-Assisted Corneal Topography/Photokeratoscopy | Retired |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Cochlear Implants, Effective 9/1/2026 | Retired |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Cochlear Implants | Retired |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Chelation Therapy for Off-Label Uses Effective 9-1-26 | Retired |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Chelation Therapy for Off-Label Uses | Retired |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Bioimpedance Devices for Detection and Management of Lymphedema | Retired |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Baroreflex Stimulation Devices | Retired |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Automated Point of Care Nerve Conduction Tests | Retired |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Intracoronary Drug Delivery Balloon Procedures Effective 9-1-26 | Retired |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Whole Exome and Whole Genome Sequencing for Diagnosis of Genetic Disorders | New policy |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Total Joint Arthroplasty – Hip and Knee | New policy |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Removal of Implantable Devices, Effective 1/1/2027 | New policy |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Radioembolization for Primary and Metastatic Tumors of the Liver, Effective 12/1/2026 | New policy |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Proteogenomic Testing for Patients with Cancer | New policy |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Prior Authorization of Spinal Procedures | New policy |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Prior Authorization of Services, Treatments or Procedures, Effective 10/1/2026 | New policy |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Prior Authorization of Services, Treatments or Procedures, Effective 1/1/2027 | New policy |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Prior Authorization of Services, Treatments or Procedures | New policy |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Prior Authorization of Physical and Occupational Therapy Services - Effective 1/1/2027 | New policy |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Prior Authorization of Physical and Occupational Therapy Services | New policy |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Prior Authorization of Drugs | New policy |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Prior Authorization for Durable Medical Equipment (DME), Effective 12/1/2026 | New policy |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Preimplantation Genetic Testing | New policy |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Out-of-Network Services Requests | New policy |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | New Technology and Miscellaneous Services, Effective 12/1/2026 | New policy |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | New Technology and Miscellaneous Services | New policy |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Multimarker Serum Testing Related to Ovarian Cancer | New policy |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Minimally Invasive Procedures for Back Pain, Effective 12/1/2026 | New policy |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Minimally Invasive Procedures for Back Pain, Effective 10/1/2026 | New policy |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Microprocessor-Controlled Prostheses for the Lower Limb Effective 12-1-26 | New policy |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Laparoscopic, Percutaneous, and Transcervical Techniques for the Myolysis of Uterine Fibroids & Hysterectomies | New policy |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Laboratory Testing Investigational Services, Effective 12/1/2026 | New policy |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Invasive Prenatal (Fetal) Diagnostic Testing, Effective 1/1/2027 | New policy |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Identification of Microorganisms Using Nucleic Acid Probes, Effective 12/1/2026 | New policy |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Germline and Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment and Immunotherapy in Breast Cancer, Effective 1/1/2027 | New policy |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Gene Expression Profiling for Cutaneous Melanoma, Effective 12/1/2026 | New policy |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Gender Affirming Care | New policy |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Evaluation of Biomarkers for Alzheimer's Disease, Effective 1/1/2027 | New policy |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Epidural Injections for Pain Management, Effective 10/1/2026 | New policy |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Cryosurgical Ablation of Miscellaneous Solid Tumors other than Renal, Liver and Prostate | New policy |
| Sep 30, 2026 | Blue Cross & Blue Shield of Rhode Island | Comprehensive Genomic Profiling for Selecting Targeted Cancer Therapies | New policy |